| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/06/1994 | CN1088986A Reshaped monoclonal antibodies against an immunoglobulin isotype |
| 07/06/1994 | CN1088936A Peg-interferon conjugates |
| 07/06/1994 | CN1088935A Hemoregulatory peptides |
| 07/06/1994 | CN1088835A Use of a peptide |
| 07/05/1994 | US5326860 Pituitary adenylate cyclase activating protein precursor |
| 07/05/1994 | US5326858 Genetic engineering; antiarthritic agents |
| 07/05/1994 | US5326782 Salts derived from 26-(dialkylaminoalkylsulphonyl)pristinamycin IIB |
| 07/05/1994 | US5326779 Method of inhibiting the advanced glycosylation of proteins using 1,2-disubstituted-benzimidazoles |
| 07/05/1994 | US5326773 Prodrug enzyme inhibitors |
| 07/05/1994 | US5326757 Pharmaceutically active antioxidant containing composition and the method of its use to prevent and treat restenosis following angioplasty |
| 07/05/1994 | US5326751 Enkephalin analogs |
| 07/05/1994 | US5326749 Macrophage activating factor from vitamin D binding protein |
| 07/05/1994 | US5326695 Platelet derived growth factor agonists |
| 07/05/1994 | US5326562 Glycosaminoglycan preservation; arthritis |
| 07/05/1994 | US5326559 Treatment of accelerated atheosclerosis with interleukin-2 receptor targeted molecules |
| 07/05/1994 | US5326558 Megakaryocytopoietic factor |
| 07/05/1994 | US5326357 Reconstituted cartridge tissue |
| 07/05/1994 | CA2112652A1 New transdominant tat variants for hiv virus |
| 07/01/1994 | EP0724633A4 Recombinant transferrins, transferrin half-molecules and mutants thereof |
| 07/01/1994 | EP0612216A4 Phospholipid antimicrobial compositions. |
| 07/01/1994 | CA2112508A1 Immunogenicity of a vaccine by incorporation of a cytokine within an immune-stimulating complex containing an antigen |
| 07/01/1994 | CA2086577A1 Potential target for immunotherapy to prevent replication of hiv (aids virus) in humans: cdna and protein for a putative regulator of hiv gag polyprotein expression reconstructed from the antisense strand of human p53 gene |
| 07/01/1994 | CA2086576A1 Potential target for an immunotherapeutic approach to stop parkinson's disease in humans: cdna and protein structure for a putative activator of human dopamine receptor and human brain ca2+ channel protein reconstructed from the antisense strand of the human app gene |
| 07/01/1994 | CA2086453A1 Marker for neurotensin receptor |
| 06/30/1994 | DE4244415A1 Peptide prepn contg e g, tri:peptide(s) Gly-His-Lys and/or Gly-Asp-Ser |
| 06/30/1994 | DE4243858A1 Aminoacid derivs. which are tachykinin antagonists |
| 06/30/1994 | CA2605872A1 Intermediates for retroviral protease inhibiting compounds |
| 06/30/1994 | CA2112314A1 Process for production of cell cultures with elevated content of endogenous cytokines |
| 06/29/1994 | EP0604185A1 Inhibitors of HIV protease useful for the treatment of aids |
| 06/29/1994 | EP0604182A2 Inhibitors of HIV protease useful for the treatment of Aids |
| 06/29/1994 | EP0603992A1 Oral administration of immunologically active biomolecules and other therapeutic proteins |
| 06/29/1994 | EP0603735A2 Monoclonal antibodies that define a unique antigen of human B-cell antigen receptor complex |
| 06/29/1994 | EP0603671A2 Process of reactivating purified membrane proteins |
| 06/29/1994 | EP0603406A1 Fowl mycoplasma antigen, gene thereof, recombinant vector containing said gene, and vaccine prepared by utilizing the same |
| 06/29/1994 | EP0603399A1 Endothelin-antagonizing peptide |
| 06/29/1994 | EP0603393A1 Recombinant human interleukin 6 with homogeneous n-terminus and production thereof |
| 06/29/1994 | EP0603337A1 Erythropoietin potentiating agents and methods for their use |
| 06/29/1994 | EP0603312A1 Novel gaba a? receptor with steroid binding sites |
| 06/29/1994 | EP0603206A1 Neurotensin method for inhibiting vascular leakage |
| 06/29/1994 | EP0603194A1 Epidermal growth factor receptor targeted molecules for treatment of inflammatory arthritis |
| 06/29/1994 | EP0603187A1 Human lactoferrin |
| 06/29/1994 | EP0565618A4 Stabilization of proteins by cationic biopolymers |
| 06/29/1994 | EP0514416B1 Bacterial peptide fraction with an immunostimulatory effect, process for making it and its use |
| 06/29/1994 | EP0470183B1 Fibroblast growth factor conjugates |
| 06/29/1994 | EP0444118B1 Pyruvate-kinase-isoenzyme-type-m2 (tumour m2-pk) specific antibodies, process for producing them and use |
| 06/29/1994 | EP0406272B1 Production of insulin-like growth factor binding protein |
| 06/29/1994 | EP0401303B1 Novel human tissue plasminogen activator variants and processes |
| 06/29/1994 | CN1088616A Method for producing large latent transforming growth factor-beta (LL-TGF beta) complexes and constructs useful therefor and method for producing large latency associated peptide (L-LAP) |
| 06/29/1994 | CN1088583A Phospholipi derivatives containing higher elements of the Vth main group |
| 06/29/1994 | CA2112523A1 2-amino-6,7- dihydroxy-4-thiaheptanoic acid derivatives, production and use thereof |
| 06/29/1994 | CA2112522A1 Tan-1511, its derivatives, production and use thereof |
| 06/28/1994 | US5324844 Active carbonates of polyalkylene oxides for modification of polypeptides |
| 06/28/1994 | US5324830 Chimeric protein that has a human RHo Motif and deoxyribonuclease activity |
| 06/28/1994 | US5324820 Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex |
| 06/28/1994 | US5324819 Protein produced by expression of DNA cell containing a pair of polypeptide chains disulfide bonded to form dimeric species having less then 200 amino acid; used for grafting in mammals |
| 06/28/1994 | US5324775 Bound to a synthetic non-immunogenic hydrophilic polyethylene glycol polymer; can be injected into humans to augment soft tissue |
| 06/28/1994 | US5324748 Method for enhancement of 1-series PG production |
| 06/28/1994 | US5324731 Method of inhibiting transformation of cells in which purine metabolic enzyme activity is elevated |
| 06/28/1994 | US5324726 Benzodiazepine analogs |
| 06/28/1994 | US5324716 Microbiocidal oligopeptide for use in human or animal therapy, fungicides, viricides, disinfectants or food preservation |
| 06/28/1994 | US5324715 Protein for inhibiting collagen-stimulated platelet aggregation |
| 06/28/1994 | US5324708 Non-hygroscopic monoammonium salts of phosphonic and phosphinic acids |
| 06/28/1994 | US5324664 Geneically engineered vaccines for cats |
| 06/28/1994 | US5324655 Human Y-interferon signal peptide-tumor necrosis factor(TNF) gene fusions |
| 06/28/1994 | US5324654 Method for reversibly increasing proliferation of a non-malignant cell population |
| 06/28/1994 | US5324652 Repeated cycles of dialysis against running water, deionized water and distilled water while varying temperatures and times |
| 06/28/1994 | US5324641 DNA sequences encoding insulin precursors and methods of production |
| 06/28/1994 | US5324638 Brain transcription factor, nucleic acids encoding same and uses thereof |
| 06/28/1994 | US5324628 Use of chymotrypsin for the inactivation of prekallikrein activator |
| 06/28/1994 | US5324524 Yeast derived mitogen |
| 06/28/1994 | US5324514 Compositions of digestive enzymes and salts of bile acids and process for preparation thereof |
| 06/28/1994 | US5324511 Contain a single flagellar (H) antigen of serotype a or a combination with an antigen of serotype b; inhibit motility of pathogens |
| 06/28/1994 | US5324510 Use of antibodies to intercellular adhesion molecule-1 (ICAM-1) in the treatment of asthma |
| 06/28/1994 | US5324508 Applying monokine produced by culturing mammalian macrophage cells to inhibit fibroblast growth in healing wounds |
| 06/28/1994 | CA1330420C Compositions containing growth hormone peptide fragments |
| 06/28/1994 | CA1330417C Organic compounds |
| 06/26/1994 | CA2111999A1 Products containing active milk proteins and process for producing the same |
| 06/24/1994 | CA2112192A1 Process for reactivating purified membrane proteins |
| 06/24/1994 | CA2111763A1 Method for minimizing and containing ischemic and reperfusion injury |
| 06/24/1994 | CA2111668A1 Process for the recovery of .alpha.-lactalbumin and .beta.-lactoglobulin from a whey protein product |
| 06/23/1994 | WO1994014067A1 Diagnosis and therapy of sarcoidosis |
| 06/23/1994 | WO1994014065A1 Methods for identifying and using immunosuppressant compounds |
| 06/23/1994 | WO1994013824A1 Retroviral vectors for the treatment of tumors, and cell lines containing them |
| 06/23/1994 | WO1994013823A1 Nucleotide sequence for treating cancer and infection |
| 06/23/1994 | WO1994013817A1 Genetically engineered glutaminase and its use in antiviral and anticancer therapy |
| 06/23/1994 | WO1994013816A1 Recombinant canine gastric lipase and pharmaceutical compositions |
| 06/23/1994 | WO1994013808A2 LYMPHOTOXIN-β, LYMPHOTOXIN-β COMPLEXES, PHARMACEUTICAL PREPARATIONS AND THERAPEUTIC USES THEREOF |
| 06/23/1994 | WO1994013807A1 Clotting inhibitor made from protostomia saliva |
| 06/23/1994 | WO1994013806A1 Multivalent single chain antibodies |
| 06/23/1994 | WO1994013804A1 Multivalent and multispecific binding proteins, their manufacture and use |
| 06/23/1994 | WO1994013802A1 D4 gene and methods of use thereof |
| 06/23/1994 | WO1994013801A1 Mammalian receptors for interleukin-10 (il-10) |
| 06/23/1994 | WO1994013800A2 Mk protein preparation and use in cell culture |
| 06/23/1994 | WO1994013799A1 Stably transfected cell lines expressing gaba-a receptors |
| 06/23/1994 | WO1994013798A1 Agents for the prevention and treatment of human alzheimer's disease |
| 06/23/1994 | WO1994013796A1 Expression cloning of a human phosphatase |
| 06/23/1994 | WO1994013791A1 Regulatable nucleic acid therapeutic and methods of use thereof |
| 06/23/1994 | WO1994013789A2 Oligonucleotides with rna cleavage activity |
| 06/23/1994 | WO1994013702A1 Composition containing hematopoiesis inhibitor |
| 06/23/1994 | WO1994013701A2 Delta-like gene expressed in neuroendocrine tumors |